Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
In the Original Investigation entitled “Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome: the SOLID-TIMI 52 Randomized Clinical Trial” published in the September 10, 2014, issue of JAMA (2014;312:1006-1015. doi:10.1001/jama.2014.11061), there were 2 errors. In the byline, the name of the fourth author should have been “Dylan L. Steen, MD.” The title of Figure 2 should have been “Primary End Point of the SOLID-TIMI 52 Trial” and the first sentence of the figure legend should have been “Cumulative incidence curves for the primary end point.” This article was corrected online.
Incorrect Byline and Figure Terminology. JAMA. 2014;312(14):1473. doi:10.1001/jama.2014.13127